Cellectar Biosciences, Inc. (CLRB)

2.76 -0.01 (-0.36%) USD  |  NASDAQ  |  Mar 06, 16:00
2.75 -0.01 (-0.36%) After-Hours: 20:00
More

Cellectar Biosciences SG&A Expense (TTM) : 8.949M for Dec. 31, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for CLRB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
EyePoint Plc 40.32M
Ocugen, Inc. 21.45M
ACADIA Pharmaceuticals, Inc. 548.89M
Alnylam Pharmaceuticals, Inc. 1.211B
Savara, Inc. 37.38M